Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular pathways mediating ROS generation and ER stress represent a complex signaling network rather than a single therapeutic target. Reactive Oxygen Species (ROS) are primarily generated by the mitochondrial electron transport chain and NADPH oxidase (NOX) enzymes, while Endoplasmic Reticulum (ER) stress is characterized by the accumulation of misfolded proteins, triggering the Unfolded Protein Response (UPR) via sensors like PERK, IRE1, and ATF6 (Hetz, 2012; Zeeshan et al., 2016). These two processes are highly interdependent; ROS can disrupt ER calcium homeostasis and protein folding, while ER stress can stimulate ROS production through the induction of ERO1 and mitochondrial dysfunction (Malhotra & Kaufman, 2007). Chronic activation of this ROS-ER stress axis is implicated in the pathogenesis of various conditions, including neurodegenerative diseases, type 2 diabetes, and cardiovascular disorders, often leading to programmed cell death (Bhat et al., 2015). Pharmacological intervention typically targets specific nodes within these pathways, such as using chemical chaperones like TUDCA to stabilize protein folding or antioxidants like N-acetylcysteine to neutralize ROS (Vang et al., 2014). Understanding the crosstalk between these pathways is crucial for developing therapies that can restore cellular proteostasis and redox balance.
Modulation of oxidative stress levels through antioxidant activity and restoration of endoplasmic reticulum proteostasis via chemical chaperoning or inhibition of UPR sensors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular pathways mediating ROS generation and ER stress.